Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia
暂无分享,去创建一个
F. Wolfe | K. Michaud | W. Häuser | R. Katz | B. Walitt | Y. Lee | Robert S. Katz | Frederick Wolfe | W. Häuser | Yvonne C. Lee | F. Wolfe
[1] K. Barker. Listening to Lyrica: contested illnesses and pharmaceutical determinism. , 2011, Social science & medicine.
[2] F. Wolfe,et al. Do We Need Core Sets of Fibromyalgia Domains? The Assessment of Fibromyalgia (and Other Rheumatic Disorders) in Clinical Practice , 2011, The Journal of Rheumatology.
[3] C. Sommer,et al. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. , 2011, Rheumatology.
[4] F. Wolfe,et al. The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank. , 2011, Rheumatology.
[5] F. Wolfe,et al. The Hawthorne Effect, Sponsored Trials, and the Overestimation of Treatment Effectiveness , 2010, The Journal of Rheumatology.
[6] C. Sommer,et al. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. , 2010, The journal of pain : official journal of the American Pain Society.
[7] M. Detke,et al. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. , 2010, Seminars in arthritis and rheumatism.
[8] D. Turk,et al. Guidelines on the management of fibromyalgia syndrome – A systematic review , 2010, European journal of pain.
[9] M. Briley. Drugs to treat fibromyalgia - the transatlantic difference. , 2010, Current opinion in investigational drugs.
[10] H. Moldofsky,et al. A 1-year Safety and Efficacy Study of Duloxetine in Patients With Fibromyalgia , 2009, The Clinical journal of pain.
[11] B. Herman,et al. Long-term safety and tolerability of pregabalin treatment in three open-label extension studies in patients with fibromyalgia , 2009 .
[12] Patrick Dattalo,et al. Statistical Power Analysis , 2008 .
[13] G. Oster,et al. Characteristics and healthcare costs of patients with fibromyalgia syndrome , 2007, International journal of clinical practice.
[14] B. Collett,et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment , 2006, European journal of pain.
[15] P. Wainwright,et al. Open label extension studies: research or marketing? , 2005, BMJ : British Medical Journal.